CFTR and cystic fibrosis-related liver disease: Although the biliary phenotype of CFLD could plausibly respond to CFTR modulation, the vascular subtype, characterized by non-cirrhotic portal hypertension, has an uncertain pathogenesis and its response to ETI is unknown.